RMTG (Regenerative Medical Technology Group) Interest Coverage: 0.10 (As of Mar. 2026) — 900% Above Median


What is Regenerative Medical Technology Group Interest Coverage?

Regenerative Medical Technology Group RMTG Interest Coverage is 0.10 as of Mar. 2026, which is 900% above its 10-year median of 0.01. The stock has 4 warning signs investors should review. Among 377 Biotechnology companies, Regenerative Medical Technology Group ranks worse than 265251.72% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Regenerative Medical Technology Group's Operating Income for the three months ended in Mar. 2026 was $0.23 Mil. Regenerative Medical Technology Group's Interest Expense for the three months ended in Mar. 2026 was $-2.19 Mil. Regenerative Medical Technology Group's interest coverage for the quarter that ended in Mar. 2026 was 0.10. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Regenerative Medical Technology Group's Interest Coverage or its related term are showing as below:


RMTG's Interest Coverage is not ranked *
in the Biotechnology industry.
Industry Median: 106.07
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Regenerative Medical Technology Group  (OTCPK:RMTG) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Regenerative Medical Technology Group Interest Coverage Related Terms

Regenerative Medical Technology Group Interest Coverage Historical Data

* Premium members only.

The historical data trend for Regenerative Medical Technology Group's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Regenerative Medical Technology Group Interest Coverage Chart

Regenerative Medical Technology Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Coverage
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.01 0.00

Regenerative Medical Technology Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.00 0.00 0.00 0.10

RMTG vs WINT, LIPO, CYTOF: Interest Coverage Comparison

For the Biotechnology subindustry, Regenerative Medical Technology Group's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerative Medical Technology Group Interest Coverage vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenerative Medical Technology Group's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Regenerative Medical Technology Group's Interest Coverage falls into.


Regenerative Medical Technology Group Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Regenerative Medical Technology Group's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Regenerative Medical Technology Group's Interest Expense was $-7.45 Mil. Its Operating Income was $-0.87 Mil. And its Long-Term Debt & Capital Lease Obligation was $2.41 Mil.

Regenerative Medical Technology Group did not have earnings to cover the interest expense.

Regenerative Medical Technology Group's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Here, for the three months ended in Mar. 2026, Regenerative Medical Technology Group's Interest Expense was $-2.19 Mil. Its Operating Income was $0.23 Mil. And its Long-Term Debt & Capital Lease Obligation was $2.43 Mil.

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*0.23/-2.191
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 0.10 mean?
Regenerative Medical Technology Group (RMTG) has a Interest Coverage of 0.10 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Regenerative Medical Technology Group and its competitors. This is 900% above median its historical median of 0.01. According to the industry distribution chart, Regenerative Medical Technology Group ranks #999999 out of 377 companies in the Biotechnology industry.
Is Regenerative Medical Technology Group's Interest Coverage too high?
Regenerative Medical Technology Group's current Interest Coverage of 0.10 is 900% above median its 10-year median of 0.01. The Biotechnology industry median Interest Coverage is 106.07. Regenerative Medical Technology Group's value of 0.10 is 99.9% below this industry median. Based on the distribution chart, Regenerative Medical Technology Group ranks #999999 out of 377 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Regenerative Medical Technology Group's Interest Coverage compare to WINT and LIPO?
According to the Biotechnology industry distribution chart, Regenerative Medical Technology Group ranks #999999 out of 377 companies for Interest Coverage. This places Regenerative Medical Technology Group in the lower half of its industry. The industry median Interest Coverage is 106.07. Regenerative Medical Technology Group's value of 0.10 is 99.9% below this benchmark. While the company's 10-year median is 0.01 vs. the industry median of 106.07, Regenerative Medical Technology Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 106.07, based on 377 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Regenerative Medical Technology Group's current Interest Coverage of 0.10 is 99.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Regenerative Medical Technology Group and its competitors. For the Biotechnology industry, the median Interest Coverage is 106.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regenerative Medical Technology Group's current Interest Coverage is 0.10, which is 900% above median its own 10-year median of 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regenerative Medical Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Regenerative Medical Technology Group (RMTG) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.06, compared to a current price of $0.05 — trading 24.7% below its estimated fair value. The current Interest Coverage is 0.10, which is 900% above median its 10-year median of 0.01 and 99.9% below the Biotechnology industry median of 106.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Regenerative Medical Technology Group (RMTG), the current Interest Coverage is 0.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regenerative Medical Technology Group Business Description

Address 433 Plaza Real, Suite 275, Boca Raton, FL, USA, 33432
Regenerative Medical Technology Group Inc is engaged in the regenerative medicine business through its subsidiary, Global Stem Cells Group. The company provides stem cell therapies, exosomes, peptides, biologics, physician training and certifications, diagnostic tools, and related clinical support services. It operates through one reportable segment, Global Stem Cells Group.